


















![]()
Q1: 2026-04-30 Earnings Summary
EPS of -$0.15 misses by $0.01
|
Revenue of
$94.47M
(27.47% Y/Y)
beats by $2.29M
Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call April 30, 2026 4:30 PM EDT
Company Participants
Lisa Caperelli
Michael Raab - President, CEO & Director
Eric Foster - Chief Commercial Officer
Sue Hohenleitner - Chief Financial Officer
Conference Call Participants
Roanna Clarissa Ruiz - Leerink Partners LLC, Research Division
Jin-Wook Kim - Citigroup Inc., Research Division
Yuchen Ding - Jefferies LLC, Research Division
Christopher Raymond - Raymond James & Associates, Inc., Research Division
Ashley Aloupis - Piper Sandler & Co., Research Division
Joseph Thome - TD Cowen, Research Division
Laura Chico - Wedbush Securities Inc., Research Division
Prakhar Agrawal - Cantor Fitzgerald & Co., Research Division
Matthew Caufield - H.C. Wainwright & Co, LLC, Research Division
Andrew Kassin - BTIG, LLC, Research Division
Presentation
Operator
Welcome to the Ardelyx First Quarter 2026 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to Lisa Caperelli, Senior Vice President of Corporate Communications and Investor Relations. Lisa, you may begin.
Lisa Caperelli
Thank you, Ross. Good afternoon, everyone, and welcome to our first quarter 2026 financial results and business update call. Earlier today, we issued our earnings release, which can be found on the Investors section of our website at ardelyx.com. Slides that accompany today's call can also be found on our website.
On today's call, I'm joined by Mike Raab, President and CEO of Ardelyx, who will share our Q1 progress towards our 2026 priorities. Eric Foster, Chief Commercial Officer, will provide an update on the performance of IBSRELA and XPHOZAH. And Sue Hohenleitner, our Chief Financial Officer, will provide some key highlights from our financial results.
Before we begin, I'd like to remind you that some of the statements made during the call today are forward-looking statements, which are subject to a number of risks and uncertainties that may cause our actual results to differ materially, including those described in
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。